+91 7986995600
seclislabs@gmail.com
Contact Us
Gastrointestinal & Hepatic Therapy

BELLYDOST

Dicyclomine Hydrochloride 10mg + Simethicone 40mg per 5mL

Dosage Form Suspension
Packing 60ml (with measuring cap)
MRP ₹90
Prescribed By Gastroenterologist, GP, Pediatrician, Internal Medicine

Quick Facts

Dicyclomine 10mg + Simethicone 40mg per 5mL; Storage Below 30°C; Schedule: H; Shake before use; Age restriction: Above 6 months only; Anticholinergic caution in susceptible patients

Key Benefits

01
Dual antispasmodic + defoaming action — addresses both components of infantile colic and GI spasm simultaneously
02
Liquid suspension — ideal paediatric formulation for precise dose titration in infants and toddlers
03
Measuring cap included — accurate dose measurement for safe paediatric administration
04
Dicyclomine's dual mechanism — both anticholinergic and direct musculotropic antispasmodic activity
05
Accessible ₹90 MRP — broadly affordable for primary care paediatric prescribing
06
60mL bottle with measuring cap — adequate supply for 1–2 week standard treatment course

Mechanism of Action

BELLYDOST is a dual-action antispasmodic and anti-flatulence suspension combining an anticholinergic antispasmodic with a defoaming agent to address the two primary components of infantile colic and gastrointestinal spasm — smooth muscle hypermotility and gas trapping.

Dicyclomine Hydrochloride (10mg per 5mL) is a tertiary amine anticholinergic that competitively blocks muscarinic acetylcholine receptors on intestinal smooth muscle cells. Acetylcholine stimulates M3 muscarinic receptors in the GI tract, causing smooth muscle contraction and increasing intestinal motility. Dicyclomine's competitive receptor blockade reduces this cholinergic stimulation, producing antispasmodic relaxation of intestinal smooth muscle — relieving the colonic hypermotility responsible for cramping abdominal pain in irritable bowel syndrome, diverticular disease, and gastrointestinal spasm. Dicyclomine also has a direct musculotropic effect on smooth muscle independent of the anticholinergic mechanism, providing more complete antispasmodic activity than pure anticholinergics.

Simethicone (40mg per 5mL) is a polydimethylsiloxane anti-foaming agent that reduces the surface tension of intestinal gas bubbles, causing them to coalesce into larger bubbles that are more easily expelled by peristalsis. This mechanical defoaming action directly relieves bloating, flatulence, and the abdominal distension caused by gas accumulation — the second major driver of colic-type abdominal pain alongside smooth muscle spasm.

Indications

Infantile Colic (Primary Indication): The most common indication for dicyclomine-simethicone suspension. Infantile colic — defined as episodes of inconsolable crying for more than 3 hours per day in otherwise healthy infants — is attributed to intestinal smooth muscle spasm and gas trapping. Dicyclomine's antispasmodic action reduces colonic smooth muscle hypertonicity while simethicone eliminates the trapped gas bubbles that cause painful distension.

Irritable Bowel Syndrome: Abdominal cramping, bloating, and flatulence associated with IBS — dicyclomine reduces the hypermotility and simethicone eliminates the associated gas accumulation.

Functional Abdominal Pain: Post-meal cramping and pain in adults and older children where combined antispasmodic and anti-flatulence effects are required.

Diverticular Disease: Symptomatic colonic spasm associated with diverticulosis — dicyclomine relieves the painful colonic contractions.

Gastroenteritis-Associated Colic: Abdominal cramping and flatulence during and after acute gastroenteritis — the suspension format enables paediatric administration.

Dosage & Administration

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.

Why BELLYDOST?

Infantile colic is one of the most distressing and common presentations in paediatric primary care — affecting approximately 20% of infants and causing significant parental anxiety and sleep disruption. BELLYDOST's combination of antispasmodic (dicyclomine) and anti-flatulence (simethicone) in a measured-dose suspension provides an accessible, practical treatment targeting both pathophysiological mechanisms of colic. The ₹90 price point ensures affordability for the primary care paediatric market where this product will predominantly be prescribed.

Interested in franchising BELLYDOST?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top